Liping Feng has devoted her entire career to improve pregnancy outcomes through innovative research. Dr. Feng conducts both basic science/laboratory research and participates in clinical studies. Her laboratory has focused on understanding the mechanisms of adverse birth outcomes, important causes of perinatal and neonates' mortality and morbidity. Currently, she has two lines of investigation focused on the roles of molecular pathways in placental trophoblast in placental development and fetal development and environmental exposure during pregnancy on birth outcomes and health of offspring including neurobehavioral development and immunity. These works are then translated to the clinical care of women through studies dedicated to identify risk factors and novel biomarkers for early prediction and prevention of adverse birth outcomes.